Literature DB >> 25443036

Trends in HIV testing, prevalence among first-time testers, and incidence in most-at-risk populations in Spain: the EPI-VIH Study, 2000 to 2009.

M Diez1, M J Bleda, J R Varela, J Ordonana, M A Azpiri, M Vall, C Santos, L Viloria, C de Armas, J M Urena, J Trullen, I Pueyo, B Martinez, T Puerta, M Vera, I Sanz, M L Junquera, M C Landa, E Martinez, M M Camara, J Belda, F J Bru, A Diaz.   

Abstract

During 2000 to 2009, data on people undergoing HIV testing and on those newly diagnosed with HIV were collected in a network of 20 Spanish clinics specialising in sexually transmitted infections and/or HIV testing and counselling. The number of tests performed, overall and disaggregated by different variables, was obtained. HIV prevalence among first-time testers and HIV incidence among repeat testers were calculated. To evaluate trends, joinpoint regression models were fitted. In total, 236,939 HIV tests were performed for 165,745 individuals. Overall HIV prevalence among persons seeking HIV testing was 2.5% (95% CI: 2.4 to 2.6). Prevalence was highest in male sex workers who had sex with other men (19.0% (95% CI: 16.7 to 21.4)) and was lowest in female sex workers (0.8% (95% CI: 0.7 to 0.9)). Significant trends in prevalence were observed in men who have sex with men (MSM) (increasing) and heterosexual individuals (decreasing). The incidence analysis included 30,679 persons, 64,104 person-years (py) of follow-up and 642 seroconversions. The overall incidence rate (IR) was 1.0/100 py (95% CI: 0.9/100 to 1.1/100). Incidence was significantly higher in men and transgender females than in women (1.8/100 py (95% CI: 1.6 to 1.9), 1.2/100 py (95% CI: 0.5 to 2.8) and 0.1/100 py (95% CI: 0.09 to 0.2) respectively) and increased with age until 35–39 years. IRs in MSM and people who inject drugs were significantly greater than in heterosexual individuals (2.5/100 py (95% CI: 2.3 to 2.7), 1.6/100 py (95% CI: 1.1 to 2.2) and 0.1/100 py (95% CI: 0.09 to 0.2) respectively), and an upward trend was observed in MSM. Our results call for HIV prevention to be reinforced in MSM and transgender women in Spain.

Entities:  

Mesh:

Year:  2014        PMID: 25443036     DOI: 10.2807/1560-7917.es2014.19.47.20971

Source DB:  PubMed          Journal:  Euro Surveill        ISSN: 1025-496X


  16 in total

1.  Genome-scale analysis of evolutionary rate and selection in a fast-expanding Spanish cluster of HIV-1 subtype F1.

Authors:  Juan Á Patiño-Galindo; Francisco Domínguez; María T Cuevas; Elena Delgado; Mónica Sánchez; Lucía Pérez-Álvarez; Michael M Thomson; Rafael Sanjuán; Fernando González-Candelas; José M Cuevas
Journal:  Infect Genet Evol       Date:  2018-09-13       Impact factor: 3.342

Review 2.  Molecular evolution methods to study HIV-1 epidemics.

Authors:  Juan Á Patiño-Galindo; Fernando González-Candelas
Journal:  Future Virol       Date:  2018-05-21       Impact factor: 1.831

3.  Awareness and Use of HIV Self-Testing Among Men Who Have Sex With Men Remains Low in Spain 2 Years After Its Authorization.

Authors:  Juan-Miguel Guerras; Juan Hoyos; Luis de la Fuente; Marta Donat; José Pulido; Luis Sordo; Patricia García de Olalla; María-José Belza
Journal:  Front Public Health       Date:  2022-06-17

4.  Differences between migrants and Spanish-born population through the HIV care cascade, Catalonia: an analysis using multiple data sources.

Authors:  J Reyes-Urueña; C Campbell; C Hernando; N Vives; C Folch; L Ferrer; L Fernández-López; A Esteve; J Casabona
Journal:  Epidemiol Infect       Date:  2017-03-08       Impact factor: 4.434

5.  The importance of accounting for testing and positivity in surveillance by time and place: an illustration from HIV surveillance in Japan.

Authors:  H Kato; K Kanou; Y Arima; F Ando; S Matsuoka; K Yoshimura; T Matano; T Matsui; T Sunagawa; K Oishi
Journal:  Epidemiol Infect       Date:  2018-09-12       Impact factor: 4.434

6.  Provider-Initiated HIV Testing for Migrants in Spain: A Qualitative Study with Health Care Workers and Foreign-Born Sexual Minorities.

Authors:  Barbara Navaza; Bruno Abarca; Federico Bisoffi; Robert Pool; Maria Roura
Journal:  PLoS One       Date:  2016-02-25       Impact factor: 3.240

7.  STI tests and proportion of positive tests in female sex workers attending local public health departments in Germany in 2010/11.

Authors:  Viviane Bremer; Karin Haar; Martyna Gassowski; Osamah Hamouda; Stine Nielsen
Journal:  BMC Public Health       Date:  2016-11-21       Impact factor: 3.295

8.  Conjunctival leiomyosarcoma: A case report and review of literature.

Authors:  Mahmood Dhahir Al-Mendalawi
Journal:  Indian J Ophthalmol       Date:  2017-11       Impact factor: 1.848

Review 9.  Global Epidemiology of HIV Infection and Related Syndemics Affecting Transgender People.

Authors:  Tonia Poteat; Ayden Scheim; Jessica Xavier; Sari Reisner; Stefan Baral
Journal:  J Acquir Immune Defic Syndr       Date:  2016-08-15       Impact factor: 3.731

10.  Immunogenicity of a novel Clade B HIV-1 vaccine combination: Results of phase 1 randomized placebo controlled trial of an HIV-1 GM-CSF-expressing DNA prime with a modified vaccinia Ankara vaccine boost in healthy HIV-1 uninfected adults.

Authors:  Susan P Buchbinder; Nicole A Grunenberg; Brittany J Sanchez; Kelly E Seaton; Guido Ferrari; M Anthony Moody; Nicole Frahm; David C Montefiori; Christine M Hay; Paul A Goepfert; Lindsey R Baden; Harriet L Robinson; Xuesong Yu; Peter B Gilbert; M Juliana McElrath; Yunda Huang; Georgia D Tomaras
Journal:  PLoS One       Date:  2017-07-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.